These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38664314)
1. Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets. Salehinia N; Mohammad Al-Mosawi AK; Al-Moussawi DK; Sadeghi ES; Zamani A; Mahdevar M Mol Biol Rep; 2024 Apr; 51(1):576. PubMed ID: 38664314 [TBL] [Abstract][Full Text] [Related]
2. An age stratified analysis of the biomarkers in patients with colorectal cancer. Yao H; Li C; Tan X Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836 [TBL] [Abstract][Full Text] [Related]
3. The identification of a common different gene expression signature in patients with colorectal cancer. Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244 [TBL] [Abstract][Full Text] [Related]
4. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454 [TBL] [Abstract][Full Text] [Related]
5. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer. Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687 [TBL] [Abstract][Full Text] [Related]
6. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer. Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510 [TBL] [Abstract][Full Text] [Related]
7. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas. Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980 [TBL] [Abstract][Full Text] [Related]
8. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer. Yue Y; Zhang Q; Sun Z Front Immunol; 2021; 12():758040. PubMed ID: 35140706 [TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis. Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282 [TBL] [Abstract][Full Text] [Related]
10. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis. Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011 [TBL] [Abstract][Full Text] [Related]
11. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related]
12. Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518 [TBL] [Abstract][Full Text] [Related]
13. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer. Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326 [TBL] [Abstract][Full Text] [Related]
14. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer. Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768 [TBL] [Abstract][Full Text] [Related]
15. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis. Fang E; Zhang X Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411 [TBL] [Abstract][Full Text] [Related]
16. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696 [TBL] [Abstract][Full Text] [Related]
17. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach. Huang C; Li R; Shi W; Huang Z Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466 [TBL] [Abstract][Full Text] [Related]
18. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related]
19. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
20. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer. Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]